ESR1 and breast carcinoma: The promoter of NHERF1 gene contains estrogen-responsive elements [38], and NHERF1 expression was correlated with increasing ER (estrogen receptor) levels in >90% of ER-positive breast carcinomas, while it is absent in ER-negative tumors associated with early recurrence and poor survival [39].